The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

Secretary Kennedy's appointment led to fears that vaccine availability would be curtailed. Those fears are now being realized.

At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...

This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing ...

San Diego doctors are expressing apprehension about the new policy on COVID-19 vaccines rolled out by the U.S. Food and Drug ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

Seven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...

FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and pericarditis ...